Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.
Scott Thomson(Centro de Estudos da Voz), Andreas Suhrbier(The University of Queensland), Rajiv Khanna(QIMR Berghofer Medical Research Institute), Dennis Moss(Australian Centre for Disease Preparedness), Barbara E.H. Coupar(QIMR Berghofer Medical Research Institute), Scott R. Burrows(Australian National University), Joy Gardner(QIMR Berghofer Medical Research Institute)
Cited by 141
Related Papers
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
|The Journal of Experimental Medicine|1992|391
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
|Proceedings of the National Academy of Sciences|1999|332
A Structural Basis for the Selection of Dominant αβ T Cell Receptors in Antiviral Immunity
|Immunity|2003|323
Estimating the global burden of Epstein–Barr virus-related cancers
|Journal of Cancer Research and Clinical Oncology|2021|313